Table 2:
Variable | Estimated Effect* | Standard Error | P Value |
---|---|---|---|
| |||
Mutation-positive | −0.0266 | 0.0124 | .04 |
EYO | −0.0005 | 0.0005 | .32 |
Mutation-positive × EYO | −0.0013 | 0.0008 | .10 |
Female sex | 0.0048 | 0.0078 | .54 |
Education (y) | −0.0007 | 0.0013 | .59 |
Apolipoprotein E4 allele positivity | 0.0036 | 0.0092 | .70 |
Mini-Mental State Examination score | 0.0022 | 0.0030 | .46 |
Normalized cerebral white matter volume (% intracranial volume) | 0.1126 | 0.2228 | .62 |
Note.—Refer to Equation (E1) (online) for full model definition. EYO = estimated years to symptom onset.
The estimated effect represents the additive effect per unit rise in the variable on the global efficiency.